Sysco (NYSE: SYY) interim CFO discloses stock and option holdings

Rhea-AI Filing Summary

SYSCO CORP interim CFO Brandon Elliot Sewell filed an initial ownership report showing his equity stake in the company. He directly holds 4,277.652 shares of common stock. The filing also lists several stock option grants, each giving him the right to buy SYSCO common shares at preset prices.

The options cover 2,492 shares at an exercise price of $76.94 expiring on August 18, 2031, 2,844 shares at $85.57 expiring on August 17, 2032, 2,507 shares at $73.53 expiring on August 9, 2033, 2,583 shares at $76.54 expiring on August 20, 2034, and 5,086 shares at $80.98 expiring on August 20, 2035. Footnotes describe standard vesting schedules, with portions of each grant becoming exercisable in annual thirds after the respective vesting start dates.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sewell Brandon Elliot

(Last) (First) (Middle)

1390 ENCLAVE PARKWAY

(Street)

HOUSTON TX 77077

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
SYSCO CORP [ SYY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,277.652	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	(1)	08/18/2031	Common Stock	2,492	$76.94	D
Stock Options (Right to buy)	(2)	08/17/2032	Common Stock	2,844	$85.57	D
Stock Options (Right to buy)	(3)	08/09/2033	Common Stock	2,507	$73.53	D
Stock Options (Right to buy)	(4)	08/20/2034	Common Stock	2,583	$76.54	D
Stock Options (Right to buy)	(5)	08/20/2035	Common Stock	5,086	$80.98	D

Explanation of Responses:

1. One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. No options may be exercised prior to 08/20/2021. Options will expire on 08/18/2031.

2. One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. No options may be exercised prior to 08/18/2023. Options will expire on 08/17/2032.

3. One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. No options may be exercised prior to 8/10/2024. Options will expire on 8/9/2033.

4. One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. No options may be exercised prior to 8/21/2025. Options will expire on 8/20/2034.

5. Stock options granted on 08/21/2025 and become exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date.

Remarks:

	/s/Andrew Wurdack, Attorney-in-Fact	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does SYSCO (SYY) interim CFO Brandon Sewell report on this Form 3?

He reports his initial ownership of SYSCO equity, including 4,277.652 common shares and multiple stock option grants. The options give rights to buy SYSCO common stock at fixed prices with expirations between 2031 and 2035.

How many SYSCO (SYY) common shares does Brandon Sewell directly own?

He directly owns 4,277.652 shares of SYSCO common stock. This figure represents his reported direct equity stake separate from any stock options, which provide future rights to acquire additional shares at specified exercise prices.

What stock options are reported for SYSCO (SYY) interim CFO Brandon Sewell?

He reports stock options over 2,492, 2,844, 2,507, 2,583 and 5,086 underlying shares, with exercise prices from $73.53 to $85.57. These options expire between August 2031 and August 2035 and follow scheduled vesting in annual thirds.

Are any buy or sell transactions disclosed for SYSCO (SYY) in this Form 3?

No buy or sell transactions are disclosed; the entries are classified as holdings. The Form 3 provides a snapshot of Brandon Sewell’s existing common stock and option positions rather than reporting new market trades in SYSCO shares.

How do the SYSCO (SYY) option grants for Brandon Sewell vest over time?

Footnotes state that one-third of the shares in several grants vest and become exercisable on each of three annual dates after the grant’s start. Another grant dated August 21, 2025 vests in roughly 33.3% increments on each of the first three anniversaries.